Risk of third and fourth tumors in patients with head and neck cancer

Head and Neck

Volumn 32, Issue 11, 2010, Pages 1467-1472

  Leãn, Xavier ^a   Martínez, Vicenç ^b   López, Montserrat ^a   García, Jacinto ^a   Quer, Miquel ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b HOSPITAL NOSTRA SENYORA DE MERITXELL   (Andorra)

Author keywords

aerodigestive tract carcinomas; carcinogenesis; head and neck cancer; second primary neoplasm; subsequent neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; FEMALE; HAZARD RATIO; HEAD AND NECK CANCER; HEAD AND NECK TUMOR; HISTOPATHOLOGY; HUMAN; HYPOPHARYNX TUMOR; LARYNX TUMOR; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MOUTH TUMOR; OROPHARYNX TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK FACTOR; SECOND CANCER; TUMOR LOCALIZATION;

AGED; CARCINOMA; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS, SECOND PRIMARY; RETROSPECTIVE STUDIES;

EID: 78649460252     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21348     Document Type: Article

References (22)

1. Warren S, Gates O,. Multiple malignant tumours: a survey of literature and statistical study. Am J Cancer 1932; 16: 1358-1414.
2. Haughey BH, Gates GA, Arfken CL, Harvey J,. Meta-analysis of second malignant tumors in head and neck cancer: the case for an endoscopic screening protocol. Ann Otol Rhinol Laryngol 1992; 101 (2 Pt 1): 105-112.
3. Tepperman BS, Fitzpatrick PJ,. Second respiratory and upper digestive tract cancers after oral cancer. Lancet 1981; 2: 547-549.
4. Cooper JS, Pajak TF, Rubin P, et al. Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys 1989; 17: 449-456.
5. León X, Quer M, Diez S, Orús C, López-Pousa A, Burgués J,. Second neoplasm in patients with head and neck cancer. Head Neck 1999; 21: 204-210.
6. Laccourreye O, Veivers FD, Hans S, Brasnu FD, Garcia D, Laccourreye FL,. Metachronous second primary cancers after successful partial laryngectomy for invasive squamous cell carcinoma of the true vocal cord. Ann Otol Rhinol Laryngol 2002; 111 (3 Pt 1): 204-209.
7. Vaamonde P, Martín C, del Río M, LaBella T,. Second primary malignancies in patients with cancer of the head and neck. Otolaryngol Head Neck Surg 2003; 129: 65-70.
8. Liao CT, Kang CJ, Chang JT, et al. Survival of second and multiple primary tumors in patients with oral cavity squamous cell carcinoma in the betel quid chewing area. Oral Oncol 2007; 43: 811-819.
9. Slaughter DP, Southwick HW, Smejkal W,. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953; 6: 963-968.
10. León X, Orús C, Quer M,. Design, maintenance, and exploitation of an oncologic database for patients with malignant tumors of the head and neck. [Article in Spanish] Acta Otorrinolaringol Esp 2002; 53: 185-190.
11. Hiyama T, Sato T, Yoshino K, Tsukuma H, Hanai A, Fujimoto I,. Second primary cancer following laryngeal cancer with special reference to smoking habits. Jpn J Cancer Res 1992; 83: 334-339.
12. Cianfriglia F, Di Gregorio DA, Manieri A,. Multiple primary tumours in patients with oral squamous cell carcinoma. Oral Oncol 1999; 35: 157-163.
13. Dikshit RP, Boffetta P, Bouchardy C, et al. Risk factors for the development of second primary tumors among men after laryngeal and hypopharyngeal carcinoma. Cancer 2005; 103: 2326-2333.
14. Do KA, Johnson MM, Doherty DA, et al. Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States). Cancer Causes Control 2003; 14: 131-138.
15. León X, del Prado Venegas MP, Orús C, López M, García J, Quer M,. Influence of the persistence of tobacco and alcohol use in the appearance of second neoplasm in patients with a head and neck cancer. A case-control study. Cancer Causes Control 2009; 20: 645-652.
16. Hsu TC, Johnston DA, Cherry LM, et al. Sensitivity to genotoxic effects of bleomycin in humans: possible relationship to environmental carcinogenesis. Int J Cancer 1989; 43: 403-409.
17. Cloos J, Spitz MR, Schantz SP, et al. Genetic susceptibility to head and neck squamous cell carcinoma. J Natl Cancer Inst 1996; 88: 530-535.
18. Cloos J, Nieuwenhuis EJ, Boomsma DI, et al. Inherited susceptibility to bleomycin-induced chromatid breaks in cultured peripheral blood lymphocytes. J Natl Cancer Inst 1999; 91: 1125-1130.
19. Schantz SP, Spitz MR, Hsu TC,. Mutagen sensitivity in patients with head and neck cancers: a biologic marker for risk of multiple primary malignancies. J Natl Cancer Inst 1990; 82: 1773-1775.
20. Gal TJ, Huang WY, Chen C, Hayes RB, Schwartz SM,. DNA repair gene polymorphisms and risk of second primary neoplasms and mortality in oral cancer patients. Laryngoscope 2005; 115: 2221-2231.
21. Minard CG, Spitz MR, Wu X, Hong WK, Etzel CJ,. Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer. Cancer 2006; 106: 2636-2644.
22. Jefferies S, Kote-Jarai Z, Goldgar D, et al. Association between polymorphisms of the GPX1 gene and second primary tumours after index squamous cell cancer of the head and neck. Oral Oncol 2005; 41: 455-461.